Based on our observations, we can hypothesize the role of CG treatment affecting RANKL expression in children treated for ALL, although no previous literature data on bone remodeling cytokines in ALL patients have been reported. This evidence concerns the gene TNFSF11 and acute lymphoblastic leukemia.